Avenue Therapeutics Sinks 25%; Shares Start Trading After Reverse Stock Split

Shares of Avenue Therapeutics, Inc. (ATXI) are down more than 25% Friday morning at $4.89.

With effect from today, Avenues shares have started trading after 1-for-15 reverse stock split

The reverse stock split was primarily intended to bring the company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing.

ATXI has traded in the range of $0.20-$6.34 in the last 1 year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Follow RTT